Literature DB >> 16357488

Prolactin suppresses GnRH but not TSH secretion.

G Page-Wilson1, P C Smith, C K Welt.   

Abstract

BACKGROUND/AIMS: In animal models, prolactin increases tuberoinfundibular dopamine turnover, which has been demonstrated to suppress both hypothalamic GnRH and pituitary TSH secretion. To test the hypothesis that prolactin suppresses GnRH and TSH secretion in women, as preliminary evidence that a short-feedback dopamine loop also operates in the human, the effect of hyperprolactinemia on GnRH and TSH secretion was examined.
METHODS: Subjects (n=6) underwent blood sampling every 10 min in the follicular phase of a control cycle and during a 12-hour recombinant human prolactin (r-hPRL) infusion preceded by 7 days of twice-daily subcutaneous r-hPRL injections. LH and TSH pulse patterns and menstrual cycle parameters were measured.
RESULTS: During the 7 days of r-hPRL administration, baseline prolactin increased from 16.0+/-3.0 to 101.6+/-11.6 microg/l, with a further increase to 253.7+/-27.7 microg/l during the 12-hour infusion. LH pulse frequency decreased (8.7+/-1.0 to 6.0+/-1.0 pulses/12 h; p<0.05) with r-hPRL administration, but there were no changes in LH pulse amplitude or mean LH levels. There were also no changes in TSH pulse frequency, mean or peak TSH. The decreased LH pulse frequency did not affect estradiol, inhibin A or B concentrations, or menstrual cycle length.
CONCLUSION: These studies demonstrate that hyperprolactinemia suppresses pulsatile LH secretion but not TSH secretion and suggest that GnRH secretion is sensitive to hyperprolactinemia, but that TSH secretion is not. These data further suggest that the degree of GnRH disruption after 7 days of hyperprolactinemia is insufficient to disrupt menstrual cyclicity. Copyright (c) 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16357488     DOI: 10.1159/000090377

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  4 in total

1.  Recombinant human prolactin for the treatment of lactation insufficiency.

Authors:  Camille E Powe; Maureen Allen; Karen M Puopolo; Anne Merewood; Susan Worden; Lise C Johnson; Amy Fleischman; Corrine K Welt
Journal:  Clin Endocrinol (Oxf)       Date:  2010-11       Impact factor: 3.478

2.  Hypothalamic-Pituitary-Ovarian Axis Reactivation by Kisspeptin-10 in Hyperprolactinemic Women With Chronic Amenorrhea.

Authors:  Robert P Millar; Charlotte Sonigo; Richard A Anderson; Jyothis George; Luigi Maione; Sylvie Brailly-Tabard; Philippe Chanson; Nadine Binart; Jacques Young
Journal:  J Endocr Soc       Date:  2017-10-16

3.  Myxedema Coma Associated with Macroprolactinoma: Case Report and Review of the Literature.

Authors:  Elizabeth Jasola Omoniyi; Richard J Robbins
Journal:  Case Rep Endocrinol       Date:  2022-04-28

4.  Short-term prolactin administration causes expressible galactorrhea but does not affect bone turnover: pilot data for a new lactation agent.

Authors:  Gabrielle Page-Wilson; Patricia C Smith; Corrine K Welt
Journal:  Int Breastfeed J       Date:  2007-07-24       Impact factor: 3.461

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.